AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 66 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $199,000 | -35.0% | 6,142 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $306,000 | -90.7% | 6,142 | -87.5% | 0.00% | -90.2% |
Q1 2019 | $3,308,000 | +46.2% | 49,054 | 0.0% | 0.04% | +32.3% |
Q4 2018 | $2,262,000 | -40.2% | 49,054 | 0.0% | 0.03% | -31.1% |
Q3 2018 | $3,783,000 | -9.3% | 49,054 | -0.9% | 0.04% | -8.2% |
Q2 2018 | $4,171,000 | +3.0% | 49,524 | 0.0% | 0.05% | 0.0% |
Q1 2018 | $4,050,000 | +51.0% | 49,524 | +5.5% | 0.05% | +53.1% |
Q4 2017 | $2,683,000 | -21.2% | 46,924 | -8.0% | 0.03% | -22.0% |
Q3 2017 | $3,405,000 | +29.8% | 51,013 | 0.0% | 0.04% | +24.2% |
Q2 2017 | $2,624,000 | +5.0% | 51,013 | +19.2% | 0.03% | +6.5% |
Q1 2017 | $2,498,000 | +30.6% | 42,780 | -6.7% | 0.03% | +29.2% |
Q4 2016 | $1,913,000 | -15.9% | 45,837 | +6.5% | 0.02% | -17.2% |
Q3 2016 | $2,274,000 | +30.8% | 43,048 | +3.7% | 0.03% | +26.1% |
Q2 2016 | $1,739,000 | +9.8% | 41,518 | +6.4% | 0.02% | +9.5% |
Q1 2016 | $1,584,000 | -29.1% | 39,018 | +13.4% | 0.02% | -25.0% |
Q4 2015 | $2,234,000 | +3.0% | 34,418 | +12.0% | 0.03% | -3.4% |
Q3 2015 | $2,169,000 | -31.6% | 30,724 | +7.6% | 0.03% | -23.7% |
Q2 2015 | $3,173,000 | +42.4% | 28,549 | +20.9% | 0.04% | +46.2% |
Q1 2015 | $2,228,000 | +56.8% | 23,622 | +86.3% | 0.03% | +62.5% |
Q4 2014 | $1,421,000 | +8.8% | 12,677 | -40.5% | 0.02% | +6.7% |
Q3 2014 | $1,306,000 | +33.8% | 21,290 | 0.0% | 0.02% | +36.4% |
Q2 2014 | $976,000 | +17.0% | 21,290 | 0.0% | 0.01% | +10.0% |
Q1 2014 | $834,000 | +31.3% | 21,290 | -19.7% | 0.01% | +42.9% |
Q4 2013 | $635,000 | +27.8% | 26,510 | +49.3% | 0.01% | +40.0% |
Q3 2013 | $497,000 | – | 17,760 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 514,711 | $22,194,338 | 5.19% |
ACUTA CAPITAL PARTNERS, LLC | 78,700 | $3,393,544 | 2.86% |
Bellevue Group AG | 3,879,548 | $167,286,110 | 2.72% |
Parkman Healthcare Partners LLC | 446,416 | $19,249,458 | 2.58% |
Eagle Health Investments LP | 330,830 | $14,265,390 | 2.50% |
SECTOR GAMMA AS | 121,844 | $5,253,913 | 1.96% |
Frazier Life Sciences Management, L.P. | 871,974 | $37,599,519 | 1.76% |
BVF INC/IL | 1,190,107 | $51,317,414 | 1.44% |
Rock Springs Capital Management LP | 1,044,261 | $45,028,534 | 1.36% |
FARALLON CAPITAL MANAGEMENT LLC | 5,654,502 | $243,822,126 | 1.15% |